Home > Insider Trading > Filing (0001179110-13-013257)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1145460	Alere Inc.	ALR	In Vitro & In Vivo Diagnostic Substances (2835)	043565120

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1383959	Dave Teitel	51 Sawyer Road, Suite 200 Waltham MA 02453	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-08-15	10,000	$21.38	14,506	No	4	M	Direct
Common Stock	Disposition	2013-08-15	10,000	$31.73	4,506	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2013-08-15	10,000	$0.00	10,000	$21.38

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-12-11	No	4	M	Direct

Footnotes

The transactions reported on this Form were made pursuant to a Rule 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options.
This price represents the average purchase price for 106 separate transactions reported on this line. The price of the transactions reported on this line range from $31.49 to $32.26. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
These options became exercisable in four equal annual installments beginning 12/11/2004.
This derivative security does not have a price.
Includes 377 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2013.